Protocols
-
Hormonal Therapy (Neoadjuvant, Adjuvant, Locally Advanced)
-
Anti-HER2 Therapy (Neoadjuvant, Adjuvant, Locally Advanced)
-
Chemotherapy (Neoadjuvant, Adjuvant, Locally Advanced)
-
Immunotherapy (Neoadjuvant, Adjuvant, Locally Advanced)
-
Targeted Therapy, Bisphosphonates (Neoadjuvant, Adjuvant, Locally Advanced)
-
Hormonal Therapy (Advanced)
-
Anti-HER2 Therapy (Advanced)
-
Chemotherapy (Advanced)
-
Immunotherapy (Advanced)
-
Bisphosphonates (Advanced)
Hormonal Therapy
(Neoadjuvant, Adjuvant, Locally Advanced)
BRAJANAS
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Anastrozole in Postmenopausal Women
BRAJEXE
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Exemestane in Postmenopausal Women
BRAJLDTAM
Adjuvant Treatment of Resected Ductal Carcinoma In Situ using Tamoxifen
BRAJLET
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Letrozole in Postmenopausal Women
BRAJLHRHAI
Neoadjuvant or Adjuvant Ovarian Suppression and Aromatase Inhibitor in Premenopausal Women with High Risk Early Stage Breast Cancer
BRAJLHRHT
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using a LHRH Agonist and Tamoxifen
BRAJTAM
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Tamoxifen
UBRAJABEAI
Treatment of Adjuvant Breast Cancer using Abemaciclib and Aromatase Inhibitor With or Without LHRH Agonist
UBRAJABET
Treatment of Adjuvant Breast Cancer using Abemaciclib and Tamoxifen With or Without LHRH Agonist
Top
Anti-HER2 Therapy
(Neoadjuvant, Adjuvant, Locally Advanced)
BRAJACTT
Neoadjuvant or Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel and Trastuzumab
BRAJACTTG
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab
BRAJDCARBT
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using DOCEtaxel, CARBOplatin, and Trastuzumab
BRAJFECDT
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab
BRAJPNCT
Alternative Neoadjuvant or Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE), CARBOplatin and Trastuzumab
BRAJPNT
Alternative Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE) and Trastuzumab
BRAJTDC
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Trastuzumab, DOCEtaxel and Cyclophosphamide
BRAJTR
Adjuvant Therapy for Breast Cancer Using Trastuzumab following the Completion of Chemotherapy (Sequential)
BRAJTTW
Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab
BRLAACDT
Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab
UBRAJKAD
Adjuvant Therapy for Breast Cancer using Trastuzumab Emtansine (KADCYLA)
Top
Chemotherapy
(Neoadjuvant, Adjuvant, Locally Advanced)
BRAJAC
Adjuvant Therapy for Breast Cancer Using DOXOrubicin and Cyclophosphamide
BRAJACT
Neoadjuvant or Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel
BRAJACTG
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide followed by PACLitaxel
BRAJACTW
Neoadjuvant or Adjuvant therapy for Early Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by Weekly PACLitaxel
BRAJCAP
Therapy of Adjuvant Breast Cancer using Capecitabine
BRAJCMFPO
(deleted 01 Sep 2023)
Adjuvant Therapy for High-Risk Breast Cancer using Cyclophosphamide (oral), Methotrexate and Fluorouracil
BRAJDAC
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Cyclophosphamide, DOXOrubicin and DOCEtaxel
BRAJDC
Adjuvant Therapy for Breast Cancer Using DOCEtaxel and Cyclophosphamide
BRAJFEC
Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide
BRAJFECD
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin, Cyclophosphamide and DOCEtaxel
BRAJPN
Alternative Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE)
BRLAACD
Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel
BRLACPNAC
Alternative NEOAdjuvant Therapy for Triple Negative Breast Cancer using CARBOplatin and PACLitaxel NAB (ABRAXANE) Followed by DOXOrubicin and Cyclophosphamide
BRLACPNACG
Alternative NEOAdjuvant Therapy for Triple Negative Breast Cancer using Dose Dense Therapy: CARBOplatin and PACLitaxel NAB (ABRAXANE) Followed by DOXOrubicin and Cyclophosphamide
BRLACTWAC
NEOAdjuvant Therapy for Triple Negative Breast Cancer using Carboplatin and Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
BRLACTWACG
NEOAdjuvant Therapy for Triple Negative Breast Cancer using Dose Dense Therapy: Carboplatin and Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
BRLAPNAC
Alternative NEOAdjuvant Therapy for Locally Advanced Breast Cancer using PACLitaxel NAB (ABRAXANE) followed by DOXOrubicin and Cyclophosphamide
BRLAPNACG
Alternative NEOAdjuvant Therapy for Breast Cancer using Dose Dense Therapy: PACLitaxel NAB (ABRAXANE) followed by DOXOrubicin and Cyclophosphamide
BRLATACG
NEOAdjuvant Therapy for Breast Cancer Using Dose Dense Therapy: PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
BRLATWAC
NEOAdjuvant Therapy for Locally Advanced Breast Cancer Using Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
Top
Immunotherapy
(Neoadjuvant, Adjuvant, Locally Advanced)
BRAJPEM
Adjuvant Treatment of Resected Triple Negative Breast Cancer using Pembrolizumab
NEOAdjuvant Therapy for Triple Negative Breast Cancer using Pembrolizumab with CARBOplatin and Weekly PACLitaxel, Followed by DOXOrubicin and Cyclophosphamide
NEOAdjuvant Therapy for Triple Negative Breast Cancer using Pembrolizumab, Weekly CARBOplatin and Weekly PACLitaxel, Followed by DOXOrubicin and Cyclophosphamide
Top
Targeted Therapy, Bisphosphonates
(Neoadjuvant, Adjuvant, Locally Advanced)
BRAJPAM
Adjuvant Therapy for Breast Cancer in Post-menopausal Women Using Pamidronate
BRAJZOL2
Adjuvant Therapy for Breast Cancer in Post-Menopausal Women Using 3-Monthly Zoledronic Acid
BRAJZOL5
Adjuvant Therapy for Breast Cancer in post-menopausal Women Using 6-Monthly Zoledronic Acid
UBRAJOLA
Treatment of BRCA-Mutated High-Risk Early Breast Cancer using Olaparib
Top
Hormonal Therapy
(Advanced)
BRAVANAS
Palliative Therapy for Metastatic Breast Cancer Using Anastrozole
BRAVEVEX
Therapy for Advanced Breast Cancer Using Everolimus and Exemestane
BRAVEXE
Palliative Therapy for Advanced Breast Cancer Using Exemestane
BRAVLET
Palliative Therapy for Advanced Breast Cancer Using Letrozole
Therapy for Advanced Breast Cancer Using a LHRH Agonist and an Aromatase Inhibitor
BRAVLHRHT
Palliative Therapy for Breast Cancer Using a LHRH agonist and tamoxifen
BRAVMEG
Palliative Therapy for Advanced Breast Cancer Using Megestrol
BRAVPALAI
Therapy of Advanced Breast Cancer Using Palbociclib and Aromatase Inhibitor With or Without LHRH Agonist
BRAVPBFLV
Therapy of Advanced Breast Cancer using Palbociclib and Fulvestrant With or Without LHRH Agonist
BRAVRBFLV
Therapy of Advanced Breast Cancer using Ribociclib and Fulvestrant With or Without LHRH Agonist
BRAVRIBAI
Therapy of Advanced Breast Cancer Using Ribociclib and Aromatase Inhibitor With or Without LHRH Agonist
BRAVTAM
Palliative Therapy for Breast Cancer Using Tamoxifen
BRAVTEST
Palliative Therapy for Metastatic Breast Cancer Using Testosterone Enanthate
Top
Anti-HER2 Therapy
(Advanced)
BRAVENH
Palliative Therapy for Metastatic Breast Cancer using Trastuzumab Deruxtecan (ENHERTU)
BRAVKAD
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab Emtansine (KADCYLA)
BRAVLCAP
Therapy for Metastatic Breast Cancer Using Capecitabine and Lapatinib
BRAVPTRAD
Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab, and DOCEtaxel as First-Line Treatment for Advanced Breast Cancer
BRAVPTRAT
Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab, and PACLitaxel as First-Line Treatment for Advanced Breast Cancer
BRAVPTRVIN
Palliative Therapy for Metastatic Breast Cancer using PERTuzumab, Trastuzumab, and Vinorelbine as First-Line Treatment for Advanced Breast Cancer
BRAVTCAP
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab and Capecitabine
BRAVTR
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab
UBRAVTTCAP
Palliative Therapy for Metastatic Breast Cancer using Trastuzumab, Tucatinib, and Capecitabine
Top
Chemotherapy
(Advanced)
BRAVA7
Palliative Therapy for Metastatic Breast Cancer Using Weekly DOXOrubicin
BRAVABR
Palliative Therapy for Metastatic Breast Cancer using PACLitaxel NAB (ABRAXANE)
BRAVAC
Palliative Therapy for Metastatic Breast Cancer Using DOXOrubicin and Cyclophosphamide
BRAVCAP
Therapy for Metastatic Breast Cancer Using Capecitabine
BRAVCMF
Palliative Therapy for Advanced Breast Cancer Using Cyclophosphamide, Methotrexate and Fluorouracil
BRAVCMPO
Palliative Therapy for Metastatic Breast Cancer Using Metronomic Low-Dose Oral Cyclophosphamide and Methotrexate
BRAVDOC
Palliative Therapy for Metastatic Breast Cancer Using DOCEtaxel
BRAVDOC7
Palliative Therapy for Metastatic Breast Cancer Using Weekly Docetaxel
BRAVENH (see under Anti-HER2 section)
BRAVERIB
Palliative Therapy for Metastatic Breast Cancer Using eriBULin
BRAVGEM
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine
BRAVGEMD
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine and DOCEtaxel
BRAVGEMP
Palliative Therapy for Metastatic Breast Cancer Using CISplatin and Gemcitabine
BRAVGEMT
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine and PACLitaxel
BRAVHDMTX
Treatment of Meningeal Disease using High-Dose Methotrexate with Leucovorin Rescue
BRAVNAV
Palliative Therapy for Symptomatic Metastatic Breast Cancer Using Vinorelbine
BRAVPGC (see under Immunotherapy section)
BRAVSG
Palliative Therapy for Metastatic Triple Negative Breast Cancer using Sacituzumab Govitecan
BRAVTAX
Palliative Therapy for Metastatic Breast Cancer Using PACLitaxel
BRAVTW
Palliative Therapy for Metastatic Breast Cancer Using Weekly PACLitaxel (3 Weeks Out of 4 Weeks Schedule)
Top
Immunotherapy
(Advanced)
BRAVPEM
Treatment of Metastatic Breast Cancer using Pembrolizumab
BRAVPEM6
Treatment of Metastatic Breast Cancer using 6-Weekly Pembrolizumab
BRAVPGC
Palliative Therapy for Metastatic Breast Cancer using Pembrolizumab, Gemcitabine, and CARBOplatin
BRAVPP
Palliative Therapy for Metastatic Breast Cancer using Pembrolizumab with PACLitaxel
BRAVPPN
Palliative Therapy for Metastatic Breast Cancer using Pembrolizumab and PACLitaxel NAB (ABRAXANE)
Top
Bisphosphonates
(Advanced)
BRAVCLOD
For Therapy of Bone Metastases in Breast Cancer Using Oral Clodronate
BRAVPAM
Prevention of Skeletal Related Events Secondary to Breast Cancer Metastases Using Pamidronate
BRAVZOL
Treatment of Acute Bone Pain Secondary to Breast Cancer Metastases Using IV Zoledronic Acid
Top